The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
| Autor: | Kelsey, J.E.1,2 jkelsey@bates.edu, Harris, O.1, Cassin, J.1 |
|---|---|
| Zdroj: | Behavioural Brain Research. Nov2009, Vol. 203 Issue 2, p304-307. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Full Text from ScienceDirect